| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |